After a week of scientific exchanges and presentation of the main results of Cuban biotechnology in the resolution of social and economic problems, the BioHabana 2022 International Congress concludes today in this capital.

On the last day of the event, cooperation agreements will be signed between BioCubaFarma and institutions, centres and companies from other parts of the world, with the aim of strengthening alliances for the production of drugs and equipment to improve the health of the population.

Speakers from the United States, Brazil, Chile, Honduras, Panama, Mexico, El Salvador and Cuba will discuss regulatory science at the symposium hosted by the archipelago’s Centre for State Control of Medicines, Equipment and Medical Devices.

Scientists and researchers from Europe and the Americas will discuss the effectiveness of immunotherapy in cancer treatment and its prospects for development worldwide.
At the event, which has been held at the Havana Convention Palace since last Monday, the island’s experiences in the fight against COVID-19, the application of biotechnology in agriculture and the procurement of medical equipment to provide the Caribbean country with sovereignty were presented.
BioHabana 2022, organised by BioCubaFarma, is attended by more than 900 national and foreign delegates and guests from 51 nations, from universities, scientific centres and institutions, and companies.

At the same time as the scientific sessions, an Exhibition Fair is being held with portfolios of exportable products from the Biotechnology and Pharmaceutical Industry Group of the largest of the Antilles.